5th International Conference on

Clinical Diabetes, Diabetic Medication & Treatment

Clinical Diabetes 2019

Theme: Conquering Diabetes and Endocrinology challenges

International Conference on Clinical Diabetes, Diabetic Medication & Treatment will be held on December 04-05, 2019 in Dubai, UAE. Clinical Diabetes 2019 is a summit designed to provide an exclusive forum for doctors, dieticians, researchers, scholars, students furthermore scientists to introduce and talk about the latest advancements, challenges encountered, trends, concerns, applications and the solutions taken up for mitigating diabetes. We invite all Doctors, Scientists, Research Scholar, Nutraceutical Industry, Healthcare Companies, Entrepreneurs, R&D Institutes, Healthcare Innovators, Public Health Professionals, Clinical Researchers, Life Science Investors, Druggists, Academic Researchers, Diabetes Societies and Associations.

Session 1: Clinical Diabetes

The Clinical Diabetes Conference gauges that the predominance of DR will triple from 2005 to 2050. Novel therapeutic mark available for diabetes includes Incretin based therapies, oral therapeutic agents likes secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 2: Type 1 Diabetes Mellitus

Diabetes mellitus type 1 (generally called type 1 diabetes) is a kind of diabetes mellitus that results from the resistant framework demolition of the insulin-conveying beta cells in the pancreas. The resulting nonappearance of insulin prompts extended glucose in the blood and urine. The set-up indications are normal urine, extended thirst, extended longing, and weight diminishment. The explanation behind diabetes mellitus type 1 is dark. Type 1 diabetes can be perceived from type 2 from autoantibody testing. The C-peptide test, which measures endogenous insulin age, can moreover be used.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 3: Type 2 Diabetes Mellitus

Type 2 diabetes is a whole deal metabolic turmoil that is depicted by high glucose, insulin protection, and relative nonappearance of insulin. Fundamental reactions join extended thirst, unending urine, and unexplained weight diminishment. Signs may moreover fuse extended longing for, feeling tired, and wounds that don't recover. Routinely signs proceed step by step. Whole deal complexities from high glucose join coronary ailment, strokes, diabetic retinopathy which can realize visual debilitation, kidney frustration, and poor circulatory system in the limbs which may incite evacuations. The sudden beginning of hyperosmolar hyperglycaemic state may happen; regardless, ketoacidosis is exceptional. This Clinical Diabetes Conference includes fields like Neuropathy and Nephropathy are the major interests of this session of the Clinical Diabetes Conference.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 4: Diabetes Ophthalmology

Diabetic retinopathy is the most well-known diabetic eye illness and a main source of visual deficiency in grown-ups in the U.S. It is caused by changes in the veins of the retina. The retina is the light-touchy tissue at the back of the eye. A solid retina is vital for good vision. Diabetic retinopathy can be recognized amid an expanded eye exam by an ophthalmologist or optometrist. An exam by your essential specialist, amid which your eyes are not enlarged, isn't a satisfactory substitute for a full exam done by an ophthalmologist. Eye exams for individuals with diabetes can include: Visual keenness testing. Diabetic retinopathy influences veins in the light-delicate tissue called the retina that lines the back of the eye. It is the most well-known reason for vision misfortune among individuals with diabetes and the main source of vision hindrance and visual impairment among working-age grown-ups. This particular session at the Diabetes Congress with throw light on this area.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 5: Endocrinology, Diseases and Disorders

The Endocrine system controls the flood of data among cells and tissues, spoke to by complex administrative parts. Hormones apply in all cases impacts on different metabolic strategies which guarantee administrative, change genic and integrative farthest point. Signs and signs of endocrine issue explore the whole clinical range. The Endocrine framework is an arrangement of organs that make and release hormones that help control various basic body limits, including the body's ability to change calories into vitality that powers cells and organs. The Clinical Diabetes Conference will be hosting the session with topics like hypothyroidism, gestational diabetes, prediabetes and osteoporosis etc.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 6: Gestational Diabetes

Gestational diabetes is first dissected during pregnancy. Like type 1 and type 2 diabetes, gestational diabetes causes glucose levels to twist up observably too high. When you eat, your stomach related system isolates most of the sustenance into a sugar called glucose. It's the time when the blood glucose level (glucose level) of the mother goes too high during pregnancy. Gestational diabetes makes when your body can't convey enough of the hormone insulin during pregnancy. Insulin is vital to transport glucose what your body uses for imperativeness into the cells. Without enough insulin, you can grow unreasonably glucose in your blood, inciting a higher-than-run of the mill blood glucose level and possibly gestational diabetes. The higher blood glucose level in gestational diabetes caused by hormones released by the placenta during pregnancy. The placenta conveys a hormone called the human placental lactogen (HPL), generally called human chorionic somatomammotropic (HCS). This session of clinical diabetes meeting will be highlighted.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 7: Endocrine Nursing and Healthcare

Endocrine Nurses help kids with endocrine illnesses. These attendants treat new born children to adolescents with deferred development and advancement, and illnesses like diabetes, hypoglycemia, and endocrine organ issue including adrenal, thyroid and pituitary issues. As in this diabetes event an Endocrinology Nurse, Endocrine Nurses help to create treatment design and care. Since a standout amongst the most well-known illnesses in pediatric endocrinology is adolescent diabetes, you'll assume a critical part in showing youngsters and their folks about the impacts of diabetes, and enable them to settle on solid way of life decisions.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 8: Diabetes and Dental Care

People with diabetes are at special risk for periodontal (gum) disease, an infection of the gum and bone that hold the teeth in place. Periodontal disease can lead to painful chewing difficulties and even tooth loss. Dry mouth, often a symptom of undetected diabetes, can cause soreness, ulcers, infections, and tooth decay. Smoking makes these problems worse.

The primary objective of diabetes administration is, beyond what many would consider possible, to re-establish starch digestion to a typical state. To accomplish this objective, people with a flat-out inadequacy of insulin require insulin substitution treatment, which is given through infusions or an insulin pump. Insulin protection, interestingly, can be amended by dietary alterations and exercise. Different objectives of diabetes administration are to avoid or treat the numerous entanglements that can come about because of the infection itself and from its treatment.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 9: Diabetes Drugs and Insulin

Insulin is a hormone made by the pancreas that enables your body to utilize sugar (glucose) from starches in the nourishment that you eat for vitality or to store glucose for some time later. Insulin helps keeps your glucose level from getting too high (hyperglycemia) or too low (hypoglycemia).

The cells in your body require sugar for vitality. In any case, sugar can't go into the greater part of your cells straightforwardly. After you eat nourishment and your glucose level ascents, cells in your pancreas (known as beta cells) are motioned to discharge insulin into your circulation system. Insulin at that point appends to and flags cells to assimilate sugar from the circulation system. Insulin is frequently portrayed as a "key," which opens the cell to enable sugar to enter the cell and be utilized for vitality.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Session 10: Advanced Treatments for Diabetes

Diabetes medications with completely new methods of activity were affirmed: exenatide infusion for individuals with type 2 diabetes, pramlintide infusion as an extra to insulin treatment for individuals with type 1 or type 2 diabetes and Sitagliptin likewise for individuals with type 2 diabetes. Some diabetes meds enable the pancreas to discharge more insulin (on the off chance that you have type 2 diabetes), others enable cells to utilize insulin better, and others shield the liver from discharging excessively glucose. The new medicines concentrate activity on hormones called incretins.

Diabetes Conference | Clinical Diabetes Workshop | Global Diabetes Conference | Diabetes Symposium | Diabetes Congress | Diabetes Meetings

Global Markat for Clinical Diabetes:

Diabetes Medicare Conference provides a worldwide stage to worldwide systems administration and trading most recent developments in diabetes and endocrinology. Diabetes Medicare Conference is a platform which brings together individuals who have an interest in different fields of endocrinology and diabetes like Adrenal Disorders, Pituitary Disorders, Diabetes and Related Complications, Diseases and Disorders of the Thyroid, Thyroid Nodules and Tumors, Gynecomastia, Lipid Disorders, Osteoporosis, Parathyroid and Calcium Disorders. Diabetes and endocrinology conference helps to explore new practices and provides information on different endocrine disorders, hormones, diabetes in pregnancy, Pediatric, adolescent, renal disease, neuropathy, thyroid problems, bariatric medicine, neuroendocrine tumors and metabolic bone diseases. Proven rehearsals request alter in the enlightenment of novice, more practice-relevant research, and closer working relationships between clinicians and researchers. An evidence-based practice also provides opportunities for endocrinologists to be more analyzed, more efficacious, well-organized, and spirited, and to exaggerate effects of the clinical judgment.The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifestyles and obesity in global population. The sub markets such the human insulin and analogues are expected to maintain dominance in the overall diabetes treatment market.

Diabetes in Asia:

According to the World Health Organization (WHO), there are around 430 million diabetics worldwide, a number that will grow to 650 million by 2040. 60% of diabetics are Asian, and diabetes is currently the 8th leading cause of death in region. By 2030, diabetes will become the 6th leading cause of death in Asia. Furthermore, diabetes increases the risk of other health issues, including stroke and heart disease.The diabetes device market was worth approximately $15 billion worldwide in 2016, with the Asian market accounting for $3 billion. The Asian diabetes device market, which includes products such as lancets, insulin pumps, and glucose monitoring devices, is growing at a rate of over 8% annually. In 2016, the Asian diabetes drug market was worth over $8 billion of the $25 billion global diabetes drug market. The diabetes drug market is expected to double by 2030 with the rising number of diabetics. Diabetes drugs include insulin, but also medications that help with other functions such as breaking down sugar and decreasing the liver’s sugar production. The global diabetes drug market is also growing at an annual rate of over 6%, with China’s diabetes drug market growing the fastest at around 10% annually.

Diabetes in Europe:

There are about 60 million people with diabetes in the European Region, or about 10.3%  of men and  9.6%  of women aged 25 years and over.Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity.Worldwide, high blood glucose kills about 3.4 million people annually. Almost 80% of these deaths occur in low- and middle-income countries, and almost half are people aged under 70 years. WHO projects diabetes deaths will double between 2005 and 2030.

Scope and Importance:

Diabetes is one of the emerging diseases, which is becoming very common nowadays. Diabetes is a metabolic disease in which the individual has high blood glucose (sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin or both. Patients with high blood sugar will experience polyuria (frequent urination), Meeting thirsty (polydipsia) and hungry (polyphagia).With the Change in life style; our endocrine system of the body is getting disturbed. Health care is important as Diseases like Diabetes, which is a metabolic syndrome is getting increases day by day. In order to get innovative, the meeting will focus on the latest and exciting innovations in all areas of Endocrinology research offering a unique opportunity for international explorers to assemble, network, and grasp new scientific innovations. The studies are more connected with the topics like Current Advances in Endocrinology & Metabolism; Chemistry, physiology, and disorders related to Hypothalamus-Pituitary Axis, Thyroid and parathyroid glands and its Disorders, Reproductive Endocrinology, Diabetic Disorders and Treatment, Energy Balance and Obesity, Treatment and Diagnosis of Endocrine Diseases, Surgery, mechanism of action of peptide hormones and receptors and steroid hormones and receptors, Glycoprotein hormones (LSH, FSH, TH, HCG, POMC), Growth hormone family (GH, hCS, Prolactin), Adrenal Hormones and Endocrine regulation. The Talk involves the major area to be covered so that at a short time, we can discuss and find the way and make a new discovery in the field of Diabetes and Endocrinology.

Why to Attend?

Diabetes Medicare Conference is an opportunity to review the current trends in diabetes and endocrinology care and treatment and supports research in all aspects of diabetes and endocrinology. To allocate advance researches, developments, technology Challenges and improvement, Alternative therapies this meeting forms an excellent learning. This meeting also invites medical and health care professionals of all levels of experience to participate in an area of career and education growth that is not easily found within the structure of the workplace.

Target Audience:

We invite all Doctors, Scientists, Research Scholar, Nutraceutical industry, and Healthcare companies, Entrepreneurs, R&D Institutes, Healthcare Innovators, Public Health Professionals, Clinical Researchers, Life Science Investors, Druggists, Diabetes Societies and Associations, Academic Researchers.

Societies Associated with Diabetes Care:

  • American Diabetes Association
  • Diabetes Technology Society
  • International Diabetes Federation
  • Society for Endocrinology
  • Endocrine Society Australia
  • Australia Diabetes Society
  • European Society of Endocrinology
  • Egyptian Association of Endocrinology, Diabetes, And Atherosclerosis
  • The American Association of Clinical Endocrinology
  • American Diabetes Association
  • Association of British Clinical Diabetologist
  • British Association of Endocrine and Thyroid Surgeons
  • British Society for Neuroendocrinology
  • British Society for Paediatric Endocrinology and Diabetes
  • International Neuroendocrine Federation
  • International Society of Endocrinology
  • International Society of Psych neuroendocrinology
  • Panhellenic Association of Endocrinologists
  • Royal Society of Medicine Endocrinology and Diabetes Section
  • Spanish Society of Endocrinology and Nutrition.

List of Universities and Research Institutes Associated with Diabetes and Endocrinology:-

  • Endocrine Society Australia
  • Australia Diabetes Society
  • European Society of Endocrinology
  • Egyptian Association of Endocrinology, Diabetes, And Atherosclerosis
  • The American Association of Clinical Endocrinology
  • American Diabetes Association
  • Association of British Clinical Diabetologist
  • British Association of Endocrine and Thyroid Surgeons
  • British Society for Neuroendocrinology
  • British Society for Paediatric Endocrinology and Diabetes
  • International Neuroendocrine Federation
  • International Society of Endocrinology
  • International Society of Psychoneuroendocrinology
  • Panhellenic Association of Endocrinologists
  • Royal Society of Medicine Endocrinology and Diabetes Section
  • Spanish Society of Endocrinology and Nutrition.

Market Growth in the Last and Upcoming Ten:

With the alarming increase in the prevalence of various hormone-related medical conditions, such as hypogonadism, diabetes, hyperthyroidism, and hypothyroidism, the global market for endocrinology drugs market has been witnessing a remarkable upsurge in its overall size and valuation. Since the incidence rate of diabetes is exceptionally high across the world, fueled by an unhealthy diet and the reducing involvement of consumers in physical activities, the global market is likely to remain to experience a high-paced rise in the years to come. The endocrinology drugs market in the Americas is expected to reach USD 41 billion by 2020, growing at a CAGR of over 6%.

The endocrinology drugs market in EMEA will exceed USD 16 billion by 2020, growing at a CAGR of over 6%. The endocrinology drugs market in APAC is expected to exceed USD 14 billion by 2020, growing at a CAGR of over 7%.key suppliers Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca and AbbVie .                                       

Due to the high prevalence of diabetes, the demand for diabetes drugs is higher than other products. Researchers expect this trend to remain so over the next few years, resulting in the high growth rate of the diabetes drug segment. The introduction of novel drug therapies and the presence of robust product pipelines in this market for the treatment of the both types of diabetes mellitus are likely to add significantly to the rise of this segment in the years to come.

  • Clinical Diabetes
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Diabetes Ophthalmology
  • Endocrinology, Diseases and Disorders
  • Gestational Diabetes
  • Endocrine Nursing and Healthcare
  • Diabetes and Dental Care
  • Diabetes Drugs and Insulin
  • Advanced Treatments for Diabetes

1 Organizing Committee Members

OCM Member
Dr. Nabil Fathy

Internal Medicine Specialist
Zagazig University
Egypt

More...